Khan Islauddin, Kaur Sukhmandeep, Rishi Arun K, Boire Breana, Aare Mounika, Singh Mandip
College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL 32307, USA.
John D. Dingell Veterans Affairs Medical Center, Department of Oncology, Wayne State University School of Medicine, Detroit, MI 48201, USA.
Biomedicines. 2024 Jun 28;12(7):1442. doi: 10.3390/biomedicines12071442.
In this study, we investigated in detail the role of cannabidiol (CBD), beta-caryophyllene (BC), or their combinations in diabetic peripheral neuropathy (DN). The key factors that contribute to DN include mitochondrial dysfunction, inflammation, and oxidative stress.
Briefly, streptozotocin (STZ) (55 mg/kg) was injected intraperitoneally to induce DN in Sprague-Dawley rats, and we performed procedures involving Randall Sellito calipers, a Von Frey aesthesiometer, a hot plate, and cold plate methods to determine mechanical and thermal hyperalgesia in vivo. The blood flow to the nerves was assessed using a laser Doppler device. Schwann cells were exposed to high glucose (HG) at a dose of 30 mM to induce hyperglycemia and DCFDA, and JC1 and Mitosox staining were performed to determine mitochondrial membrane potential, reactive oxygen species, and mitochondrial superoxides in vitro. The rats were administered BC (30 mg/kg), CBD (15 mg/kg), or combination via i.p. injections, while Schwann cells were treated with 3.65 µM CBD, 75 µM BC, or combination to assess their role in DN amelioration.
Our results revealed that exposure to BC and CBD diminished HG-induced hyperglycemia in Schwann cells, in part by reducing mitochondrial membrane potential, reactive oxygen species, and mitochondrial superoxides. Furthermore, the BC and CBD combination treatment in vivo could prevent the deterioration of the mitochondrial quality control system by promoting autophagy and mitochondrial biogenesis while improving blood flow. CBD and BC treatments also reduced pain hypersensitivity to hyperalgesia and allodynia, with increased antioxidant and anti-inflammatory action in diabetic rats. These in vivo effects were attributed to significant upregulation of AMPK, sirT3, Nrf2, PINK1, PARKIN, LC3B, Beclin1, and TFAM functions, while downregulation of NLRP3 inflammasome, NFκB, COX2, and p62 activity was noted using Western blotting.
the present study demonstrated that STZ and HG-induced oxidative and nitrosative stress play a crucial role in the pathogenesis of diabetic neuropathy. We find, for the first time, that a CBD and BC combination ameliorates DN by modulating the mitochondrial quality control system.
在本研究中,我们详细研究了大麻二酚(CBD)、β-石竹烯(BC)或它们的组合在糖尿病周围神经病变(DN)中的作用。导致DN的关键因素包括线粒体功能障碍、炎症和氧化应激。
简而言之,腹腔注射链脲佐菌素(STZ)(55mg/kg)以诱导Sprague-Dawley大鼠发生DN,我们进行了涉及兰德尔·塞利托卡尺、冯·弗雷触觉测量仪、热板和冷板法的实验,以确定体内的机械性和热痛觉过敏。使用激光多普勒装置评估神经的血流量。将雪旺细胞暴露于30mM剂量的高葡萄糖(HG)中以诱导高血糖,并进行DCFDA、JC1和Mitosox染色,以在体外确定线粒体膜电位、活性氧和线粒体超氧化物。通过腹腔注射给大鼠施用BC(30mg/kg)、CBD(